Close this search box.

Clients & Partners

We are proud to manage some of the leading global and regional brands.

About Us

Phoenix Clinical Research is a regional dynamic full-service Contract Research Organization (CRO) established in Lebanon. Its objective is to cover the whole Middle East and North Africa region.

Why Phoenix CR?

Phoenix Clinical Research is one of the very few full service CROs in the MENA region that is ISO accredited.

Phoenix Clinical Research combines the flexibility and responsiveness of its structure coupled with more than 18 years of international and regional expertise.

Phoenix CR was the first Clinical Research Organization (CRO) to monitor a Phase I study in Egypt.

Our team helped rescue several clinical trials in the region after handover from other international and regional clinical research organizations (CROs).

We are very known for the quality of our deliverables as we aim to bring the Swiss standards to the Middle East.


Have a Look at Our Latest News

Challenges of the MENA region and how we overcome them

Challenges of the MENA region and how we overcome them Conducting clinical trials in the Middle East and North Africa (MENA) region offers a multitude of opportunities, yet it also presents unique challenges that biotech companies must carefully navigate. Understanding and effectively addressing these challenges

Read More »

Why Small-Medium Biotechs need MENA.

The Middle East and North Africa (MENA) region presents a unique landscape for clinical research, particularly for studies focused on orphan diseases and rare genetic conditions. While these diseases might be less prevalent in Western countries, they are notably more common in the MENA region

Read More »

Why MENA Region

  • Ideal to conduct genetic studies with high rates of consanguinity that could reach 70% in certain regions.
  • Western lifestyle habits increased the prevalence of cancer, cardiovascular and metabolic diseases.
  • GCC countries have the second highest prevalence of type 2 diabetes worldwide.
  • It has the highest incidence of pulmonary infections in the world.
  • Study start-ups can be achieved in less than three months in some countries.
  • The majority of investigators and study site staff are fluent in English.
  • Many Middle Eastern hospitals have been granted the Joint Commission International Accreditation.
  • The increase in life expectancy.